Psychedrine en es it fr

Psychedrine Brand names, Psychedrine Analogs

Psychedrine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

Psychedrine Chemical_Formula

C9H13N

Psychedrine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

Psychedrine fda sheet

Psychedrine msds (material safety sheet)

Psychedrine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

Psychedrine Molecular Weight

135.206 g/mol

Psychedrine Melting Point

Volatizes slowly at room temperature

Psychedrine H2O Solubility

Slightly

Psychedrine State

Solid

Psychedrine LogP

1.799

Psychedrine Dosage Forms

Capsules

Psychedrine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

Psychedrine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

Psychedrine Absorption

It forms easily absorbed molecules that are highly lipid soluble

Psychedrine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

Psychedrine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

Psychedrine Organisms Affected

Humans and other mammals